Physician profile
Heidi Templin
NPI 1790020055
$933.23
in general payments reported to CMS, 2019-2025
13 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $284 · 2024: $324 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $149.14 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.72 | 2023-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $132.52 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $117.17 | 2022-2025 | Verquvo, Keytruda, Recarbrio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.50 | 2022-2025 | Lifevest |
| Amgen INC. | $73.00 | 2025 | Repatha |
| Abbott Laboratories | $43.84 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $40.41 | 2023-2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $37.61 | 2025 | |
| Daiichi Sankyo INC. | $29.10 | 2023 | Injectafer |
| Abiomed | $28.63 | 2024 | Impella |
| Pfizer INC. | $22.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.19 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Templin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.